Skip to content

A Single Arm Pilot Trial of a Social Network Intervention

A Single Arm Pilot Trial of a Social Network Intervention (SONATA) for Older Patients With Cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05745038
Acronym
SONATA
Enrollment
330
Registered
2023-02-27
Start date
2023-11-29
Completion date
2028-06-30
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

geriatric oncology

Brief summary

The purpose of this study is to see if a social network support program (SOcial Networks to Activate Trust & Adherence or SONATA) is helpful for older individuals receiving cancer treatment. The SONATA program will last for about 4 months. There are a total of 6 coaching sessions. The first 5 sessions will be held approximately every 1 to 2 weeks. Session 6 or the final session will be held approximately 1 to 2 months after session 5. Each session will last for about 1 to 2 hours.

Detailed description

The objective of this study is to conduct a single arm pilot study to assess the feasibility and acceptability of the SONATA intervention among older patients with advanced cancer. We hypothesize that the SONATA intervention will be feasible \[≥70% enrolled patient subjects (excluding those who die during the study) will complete at least 3 of the SONATA sessions\] and acceptable \[average patient subject general acceptability score ≥4 (range one to five) using the Theoretical Framework of Acceptability questionnaire.\]

Interventions

BEHAVIORALSONATA

The SONATA intervention is composed of five components, network diagnostics, network engagement, opportunity creation, skill building and goal-setting, and feedback, that will be audio-recorded and held over six scheduled sessions.

Sponsors

University of Rochester
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

None (Open Label)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patient Inclusion Criteria: 1. Age ≥60 years 2. A diagnosis of advanced or likely incurable cancer, as determined by the primary oncologist 3. Able to speak English 4. Able to provide informed consent

Exclusion criteria

1\) Any psychiatric or cognitive impairments interfering with participation as determined by the primary oncology team Network Members: Inclusion Criteria: 1. Age ≥18 years 2. Identified as a network member by patient subjects (up to 10 network members) 3. Able to speak English 4. Able to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility - SONATA Intervention20 WeeksNumber of patients approached who consent
Acceptability- SONATA Intervention20 WeeksAverage general acceptability score using the Theoretical Framework of Acceptability questionnaire. An eight item (range 1 to 5 for each item) psychometrically validated and theoretically informed tool which assesses the following constructs - affective attitude, burden, ethicality, perceived effectiveness, intervention coherence, self-efficacy, opportunity costs, and general acceptability.

Secondary

MeasureTime frameDescription
Estimate - Social Support20 WeeksAssessed using the Medical Outcomes Study Social Support Survey. The Medical Outcomes Study Social Support Survey is a 19-item survey (range 1-5 for each item) to assess four domains of emotional/informational support, instrumental support, positive social interaction, and affection; higher scores indicate greater social support. Subjects will be asked about their perceptions of their own social support.
Estimate - Trust in Healthcare Professionals20 WeeksAssessed using the the Human Connection (THC) Scale. The THC scale is A 16-item scale (range 1 to 4 for each item); higher scores indicate greater trust.
Estimate - Adherence to oral anticancer treatments20 WeeksAssessed using the Domains of Subjective Extent of Nonadherence (DOSE-Nonadherence). The DOSE-Nonadherence scale is a three-item scale (range from none of the time to every time for each item) with eighteen additional items that assesses reasons for non-adherence.

Countries

United States

Contacts

CONTACTKah Poh Loh
Kahpoh_Loh@URMC.Rochester.edu585-276-4353
CONTACTBecky Gravenstede
becky_gravenstede@urmc.rochester.edu585-727-4728
PRINCIPAL_INVESTIGATORKah Poh Loh

University of Rochester

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 11, 2026